Search Results for: advanced

For Immediate Release Chicago, IL – July 10, 2009 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the...

Google Chrome: The science of free economics Google Inc. (GOOG) has announced a new operating system that is specifically targeted at netbooks. The Google Chrome, as it is called, is expected to hit the market in the second half...

For Immediate Release Chicago, IL – July 9, 2009 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the...

Helen of Troy Ltd. (HELE) came out this morning with its fiscal first-quarter report, which included better-than-expected earnings per share. As a result, shares are up more than 9% today, making HELE a Zacks #1 Rank Top...

Echelon Accelerates Smart Grid Adoption As a leading provider of smart grid meters, Echelon (ELON) is well positioned in the rapidly growing advanced metering infrastructure (AMI) market. On July 7, 2009, Echelon, in partnership...

Based in Dallas, Texas, Celanese Corporation (CE), a leading global chemical company, announced that it would release its second quarter 2009 results on Tuesday, July 28, 2009. In the first quarter of 2009, the company had...

The International Monetary Fund (IMF) just raised its outlook for worldwide economic growth for 2010. As shown in the table below (from http://www.imf.org/external/pubs/ft/survey/so/2009/RES070809A.htm) overall economic growth...

Semtech Seeks Margin Expansion in Analog WorldAnalog products do not require leading edge manufacturing process In general, digital semiconductor OEMs’ products are differentiated on cost of production rather than application....

Denosumab Shows Superiority To ZometaOn July 7, 2009, Amgen (AMGN) released results from a phase III program testing its experimental osteoporosis drug, denosumab, in a head-to-head trial against Novartis’ (NVS) Zometa...